Published in Eur J Cancer on October 12, 2009
Is There a Relationship between Ovarian Epithelial Dysplasia and Infertility? Obstet Gynecol Int (2012) 0.82
Reversal of tubo-ovarian atypical epithelial patterns after cessation of ovarian stimulation by letrozole. Int J Exp Pathol (2016) 0.75
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol (2005) 3.34
Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism? Br J Cancer (2006) 2.75
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 2.66
Sites of ectopic pregnancy: a 10 year population-based study of 1800 cases. Hum Reprod (2002) 2.63
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet (2001) 2.50
Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol (2013) 2.33
WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene (2001) 2.32
Second-look laparoscopy after laparoscopic cystectomy of large ovarian endometriomas. Fertil Steril (1992) 2.17
Incidence of ectopic pregnancy. First results of a population-based register in France. Hum Reprod (1994) 2.12
[Surgical treatment for endometrial adenocarcinoma: first approaches. Review of the literature]. Gynecol Obstet Fertil (2003) 2.02
The learning curve of total laparoscopic hysterectomy: comparative analysis of 1647 cases. J Am Assoc Gynecol Laparosc (2002) 1.99
[Does endoscopic surgery have a role in radical surgery of cancer of the cervix uteri?]. J Gynecol Obstet Biol Reprod (Paris) (1990) 1.96
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Cancer genetics clinics: target population and consultees' expectations. Eur J Cancer (1996) 1.88
Prognostic significance of a complete pathological response after induction chemotherapy in operable breast cancer. Br J Cancer (2002) 1.76
Fertility following radical, conservative-surgical or medical treatment for tubal pregnancy: a population-based study. BJOG (2000) 1.68
The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res (2000) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review). Int J Oncol (2000) 1.60
The relationship between MIB-1 proliferation index and outcome in pancreatic neuroendocrine tumors. Am J Clin Pathol (1998) 1.59
Interleukin-6 overexpression as a marker of malignancy in human gliomas. J Neurosurg (2001) 1.57
[Laparoscopy and gynecologic cancer: is it still necessary to debate or only convince the incredulous?]. Gynecol Obstet Fertil (2001) 1.50
Prognostic value of initial tumor parameters after metastatic relapse. Cancer Invest (2011) 1.45
[Initial or interval debulking surgery for advanced stage ovarian cancer: state-of-the-art. How to select patients?]. Gynecol Obstet Fertil (2005) 1.44
Time relationships between basal body temperature and ovulation or plasma progestins. Fertil Steril (1984) 1.43
[Mixed müllerian tumours of the endometrium. About four cases developed on tamoxifen treatment]. Gynecol Obstet Fertil (2003) 1.40
Surveillance of heterosexually acquired HIV infection and AIDS. Lancet (1995) 1.40
[Laparoscopic treatment of endometriomas: cystectomy or destruction? For laparoscopic cystectomy]. Gynecol Obstet Fertil (2000) 1.38
[Modalities and limits of conservative treatment of adenocarcinoma in situ of the uterine cervix: analysis of nine cases and review of the literature]. Gynecol Obstet Fertil (2003) 1.37
[Is there still a place for extemporaneous exam in breast cancer?]. Gynecol Obstet Fertil (2006) 1.37
Treatment of ectopic pregnancy by means of laparoscopy. Fertil Steril (1980) 1.34
Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet (1995) 1.32
Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway. Oncogene (2001) 1.32
Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer. Br J Cancer (2005) 1.31
Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. J Clin Microbiol (2005) 1.29
Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood (2000) 1.27
Laparoscopic management of adnexal torsion. A review of 35 cases. J Reprod Med (1989) 1.27
Does prevention of intraperitoneal spillage when removing a dermoid cyst prevent granulomatous peritonitis? BJOG (2010) 1.24
Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study. Histopathology (2003) 1.23
Impact of rapid enterovirus molecular diagnosis on the management of infants, children, and adults with aseptic meningitis. J Med Virol (2009) 1.19
Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol (2009) 1.18
Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine. Obstet Gynecol (1995) 1.17
Agreement between chromogenic in situ hybridisation (CISH) and FISH in the determination of HER2 status in breast cancer. Br J Cancer (2003) 1.17
The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database. BJOG (2010) 1.16
Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr Relat Cancer (2009) 1.16
Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment. AIDS Care (2004) 1.13
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res (1998) 1.12
Expression of the FGFR1 gene in human breast-carcinoma cells. Int J Cancer (1994) 1.11
Prognostic factors for patients with advanced stage serous borderline tumours of the ovary. Ann Oncol (2003) 1.10
Meconium ileus and intestinal atresia in fetuses and neonates. Pediatr Pathol Lab Med (1996) 1.10
[Partial deletion 10qter. A new case]. Ann Genet (1987) 1.10
Birth after combination of cryopreservation of sperm recovered from urine and intracytoplasmic sperm injection in a case of complete retrograde ejaculation. Fertil Steril (1997) 1.09
Ruptured tubal ectopic pregnancy: risk factors and reproductive outcome: results of a population-based study in France. Am J Obstet Gynecol (1999) 1.09
Attitudes towards cancer predictive testing and transmission of information to the family. J Med Genet (1996) 1.08
p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results. Br J Cancer (1994) 1.07
Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer. Ann Oncol (2007) 1.07
Conservative laparoscopic treatment of 321 ectopic pregnancies. Fertil Steril (1986) 1.05
Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol (2000) 1.04
Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer (1992) 1.04
Identification of novel germline hMLH1 mutations including a 22 kb Alu-mediated deletion in patients with familial colorectal cancer. Cancer Res (1996) 1.02
Genotype-phenotype correlations in fetuses and neonates with autosomal recessive polycystic kidney disease. Kidney Int (2009) 1.02
New molecular assays to predict occurrence of cytomegalovirus disease in renal transplant recipients. J Infect Dis (2000) 1.02
Prognosis of stage III or IV primary peritoneal serous papillary carcinoma. Eur J Surg Oncol (2004) 1.01
Study of two markers of apoptosis and meiotic segregation in ejaculated sperm of chromosomal translocation carrier patients. Hum Reprod (2005) 1.01
Risk factors for extrauterine pregnancy in women using an intrauterine device. Fertil Steril (2000) 1.00
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial). HIV Med (2004) 1.00
Comparison of B-mode ultrasound and computed tomography in the diagnosis of maxillary sinusitis in mechanically ventilated patients. Crit Care Med (2001) 0.99
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. Ann Oncol (2009) 0.99
Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines. Biochem Biophys Res Commun (2000) 0.99
Leptin: a proliferative factor for breast cancer? Study on human ductal carcinoma. Biochem Biophys Res Commun (2005) 0.99
[Segmental absence of colonic muscularis propria. Report of a case in an adult]. Ann Pathol (1997) 0.98
Centropontine myelinolysis after correction of hyponatremia: role of associated hypokalemia. Clin Nephrol (2007) 0.98
Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study. Ann Oncol (2003) 0.98
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classes. Ann Oncol (2008) 0.98
Is Nottingham prognostic index useful after induction chemotherapy in operable breast cancer? Br J Cancer (2003) 0.97
[Incidence of extra-uterine pregnancy and characteristics of treated patients. First results of the Auvergne registry]. Presse Med (1995) 0.97
CO2 laser laparoscopy. Baillieres Clin Obstet Gynaecol (1989) 0.97
Personalized cancer medicine and the future of pathology. Virchows Arch (2011) 0.97
A preoperative classification to predict the intrauterine and ectopic pregnancy rates after distal tubal microsurgery. Fertil Steril (1986) 0.96
Comparative clinical and transcriptomal profiles of breast cancer between French and South Mediterranean patients show minor but significative biological differences. Cancer Genomics Proteomics (2009) 0.96
Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial. Br J Dermatol (2012) 0.96
Laparoscopic diagnosis of adnexal cystic masses: a 12-year experience with long-term follow-up. Obstet Gynecol (1994) 0.96
Uterine tumor resembling ovarian sex cord tumors: report of a case with ultrastructural study. Hum Pathol (1986) 0.96
Recombinant humanised anti-HER2/neu antibody (Herceptin) induces cellular death of glioblastomas. Br J Cancer (2004) 0.95
Laparoscopic distal tuboplasty: report of 87 cases and a 4-year experience. Fertil Steril (1991) 0.95
Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer (1999) 0.95
Ovarian response during IVF-embryo transfer cycles after laparoscopic ovarian cystectomy for endometriotic cysts of >3 cm in diameter. Hum Reprod (2001) 0.95
[Duplication of the digestive tract in children. Apropos of 12 cases]. Ann Chir (1995) 0.95
Contribution of the BRCA1 and BRCA2 mutations to breast cancer in Tunisia. J Hum Genet (2007) 0.95